Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story
Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story is a paper indexed in PICO Portal from OpenAlex.
How many citations does Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story have?
Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story has 86 citations in the OpenAlex counts PICO Portal stores.
When was Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story published?
Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story has 2016 year in the PICO Portal index.
What is the open-access status of Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story?
Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story has hybrid oa status in the PICO Portal index.
What is the DOI of Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story?
The DOI for Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story is on the source record.
What is the PMID of Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story?
The PMID for Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story is on the source record.
What is the OpenAlex record for Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story?
The OpenAlex for Paving the way of systems biology and precision medicine in allergic diseases: the Me <scp>DALL</scp> success story is on the source record.